Investors

Mission

To Give Everyone The Power To Be In Control of Their Own Health

Prenetics is a leading genetics and diagnostic health testing company, operational in 10 countries with a team of over 500, led by visionary entrepreneur, Danny Yeung. Prenetics has received over USD 85-million in strategic funding from Alibaba Hong Kong Entrepreneurs Fund, Ping An Ventures, Apis Partners and more.

Prenetics has to-date performed more than 6 million diagnostic and genetic tests in Hong Kong and the United Kingdom. In Hong Kong, Prenetics was the 1st private laboratory to have been appointed by the Hong Kong government for mass community Covid-19 testing. In the United Kingdom, Prenetics was instrumental in the re-start of the English Premier League season having done the testing across 20 clubs. Prenetics mission is to decentralize health care, and focuses on the comprehensive testing capabilities covering prevention, diagnostics, and personalized care.

Investors
Presentation

Download the latest Investor
Presentation below

Press
Release

[September 16, 2021] - Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly-Traded on the Nasdaq via Merger with Adrian Cheng’s Artisan Acquisition Corp.

View Press Release
Press Release
November 10, 2021

Prenetics Announces Strong First Half 2021 Financial Results as Company Progresses Towards a U.S. Nasdaq Listing in Partnership with Artisan Acquisition Corp.

September 16, 2021

Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly-Traded on the Nasdaq via Merger with Adrian Cheng’s Artisan Acquisition Corp.

Get in touch

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.